Genezen Secures $18.5 Million In Growth Equity To Expand Viral Vector Development And Manufacturing Capabilities
Amount Raised
$18.5 Million
Round Type
Private Equity
IndianapolisManufacturingBiotechnologyInvestors
Description
Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced the closing of an $18.5 million follow-on growth equity investment led by Ampersand Capital Partners. The financing will accelerate Genezen's growth trajectory in retroviral, lentiviral and adeno-associated viral (AAV) vector manufacturing and support the execution of a robust pipeline of customer projects for innovators developing groundbreaking cell and gene therapies.
Quick answer
Genezen raised $18.5 Million in a Private Equity round, dated November 2, 2023. Investors: Ampersand Capital Partners. Genezen is based in Indianapolis, Indiana, United States.
- How much did Genezen raise?
- Genezen raised $18.5 Million in a Private Equity round on November 2, 2023.
- Who invested in Genezen?
- Ampersand Capital Partners is named as investors in this round.
- What does Genezen do?
- Genezen is a rapidly growing top-tier CDMO with over a decade of experience and state-of-the-art viral vector manufacturing facilities.
- Where is Genezen based and how big is it?
- Genezen is based in Indianapolis, Indiana, United States.
- Who are the decision-makers at Genezen?
- Fundz holds 1 contact at Genezen. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as Genezen that raised within 45 days of this round, from Fundz verified event records.
- PlasmaGen Biosciences raised $27M on December 14, 2023.
- Procyrion raised $58M on December 13, 2023.
- Hadrian raised $86M on December 11, 2023.
- Fennec Pharmaceuticals raised $5M on December 5, 2023.
- Rubi Laboratories raised $5.1M on November 30, 2023.
- QuantumDiamonds raised $7.7M (Funding Round) on November 27, 2023.
Who to call at Genezen, and when
A new round usually means Genezen is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Genezen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genezen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genezen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genezen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Genezen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.